论文部分内容阅读
美《医学世界新闻》第21卷第31期(1980年)报道贝塞斯达消息:在治疗急性、骨髓性白血病中,抗肿瘤药物柔毛霉素即将由美国食品药物管理局(FDA)批准。此药类似阿霉素,是由链丝菌提取的。研究人员说,两种药物在对抗急性、骨髓性白血病(AML)的作用方面大致相等。柔毛霉素(商品名Cerubidine),由艾夫斯药厂制造,已在市场出售,似乎没有阿霉素的某些副作用。在国家肿瘤研究所主持的讨论会上,研究
21st Century Medical News 21 (31st December, 1980) Bethesda News: In the treatment of acute, myeloid leukemia, the antitumor drug daunomycin is approved by the U.S. Food and Drug Administration (FDA) . This drug is similar to doxorubicin and is extracted from streptococcus. The researchers said the two drugs are roughly equal in their fight against acute myeloid leukemia (AML). Daunorubicin (Cerubidine), manufactured by Ives Pharmaceuticals, is on the market and appears to lack some of the side effects of doxorubicin. At the seminar hosted by the National Cancer Institute, research